Filter
206
Filtered Results: 206
Text search:
adenovirus
Featured
Recommendations
24
New Publications
30
Language
Document type
Guidelines
73
No document type
67
Studies & Reports
20
Fact sheets
15
Manuals
13
Strategic & Response Plan
6
Training Material
3
Resource Platforms
3
Situation Updates
2
Infographics
2
Brochures
1
Videos
1
Countries / Regions
Brazil
15
Germany
12
India
9
Paraguay
6
South Africa
6
Latin America and the Carribbean
5
Western and Central Europe
5
West and Central Africa
4
Kenya
3
Guinea
3
Global
3
Argentina
3
Colombia
2
Rwanda
2
Africa
2
United Kingdom
2
East and Southern Africa
2
Bangladesh
2
Ecuador
2
Myanmar / Burma
2
Ukraine
1
El Salvador
1
Sierra Leone
1
China
1
Chile
1
Burkina Faso
1
Peru
1
Philippines
1
Italy
1
USA
1
Venezuela
1
Congo, Democratic Republic of
1
Bolivia
1
Uganda
1
Eastern Europe
1
Russia
1
Ethiopia
1
Honduras
1
Chad
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
18
Key Resources
9
Women & Child Health
4
Pharmacy & Technologies
4
Public Health
3
Capacity Building
1
Toolboxes
COVID-19
94
Ebola & Marburg
22
Rapid Response
14
AMR
8
TB
6
Refugee
4
Pharmacy
4
NTDs
4
Zika
4
Planetary Health
3
Specific Hazards
2
HIV
2
Caregiver
2
Mental Health
1
Cholera
1
Conflict
1
Global Health Education
1
Arbovirus (arthropod-borne virus) is defined as any virus that is transmitted to humans and/or other vertebrates by certain species of blood-feeding arthropods, mostly insects (flies and mosquitoes) and arachnids (ticks). Arbovirus is a descriptive term based on transmission by vectors with particul...
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Learn about the composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of Utah School of Medicine.
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
Ausgabe 2015 (kommentierte Version); gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG
In dieser Version sind die wichtigsten Änderungen zur Vorversion der Falldefinitionen markiert und durch Randnotizen erläuter...
gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von
Infektionskrankhei ten beim Menschen (Infektionsschutzgesetz - I fSG)
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Ficha de Notificación e Investigación Epidemiológica Hepatitis Aguda Grave de origen Desconocido
Actualizatión 16.05.2022
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
